Table 2.
Factors Considered in the Clinical Management of COVID-19 Patients and the Maintenance of Ventilators (N= 502)*
Characteristics | Values |
---|---|
Initial diagnostic tool used for therapy initiation | |
● Arterial Blood Gas | 241 (48%) |
● Chest Imaging | 42 (8.4%) |
● Clinical Presentation | 188 (37.5%) |
● All of the Above | 31 (6.2%) |
Available protocols | |
● HFNC | 195 (38.8%) |
● NIV | 284 (56.6%) |
● IMV | 416 (82.9%) |
Used COVID-19 guidelines | |
● Own practice | 197 (39.2%) |
● National | 307 (61.2%) |
● WHO | 239 (47.6%) |
● AARC | 128 (25.5%) |
● NICE | 63 (12.5%) |
● ANZICS | 29 (5.8%) |
● SCCM | 197 (39.2%) |
Initial ventilation strategy based on severity | |
MILD | |
|
270 (53.8%) |
|
123 (24.5%) |
|
24 (4.8%) |
Moderate | |
|
87 (17.3%) |
|
236 (47%) |
|
130 (25.9%) |
SEVERE | |
|
5 (1%) |
|
15 (3%) |
|
462 (92%) |
Ventilator management | |
Suctioning system used | |
|
35 (7%) |
|
467 (93%) |
Ventilator system check | |
|
270 (53.8%) |
|
53 (10.6%) |
|
67 (13.3%) |
|
112 (22.3%) |
Note: *All percentages are expressed corresponding to the total number of respondents.
Abbreviations: AARC, American Association for Respiratory Care; ANZICS, Australian and New Zealand Intensive Care Society; HFNC, high flow nasal cannula; IMV, invasive mechanical ventilation; NICE, National Institute for Health and Care Excellence; NIV, noninvasive ventilation; SCCM, Society of Critical Care Medicine; WHO, World health Organization.